Featured Research

from universities, journals, and other organizations

Fish Fend Off Invading Germs With An Initial Response Similar To One Found In Humans

Date:
September 26, 2009
Source:
The Company of Biologists
Summary:
A new study demonstrates that the same proteins produced by humans early during infection are also made by fish early after exposure to harmful germs. These proteins activate the fish immune system in a process that resembles that in humans. But unlike humans, the inflammatory response in young zebrafish is simple, making it easier to tease out the pathways involved in the fight against infection.

Since the human response to infection is highly complex, research to understand how people fight infection is facilitated by studying how similar processes occur in simpler organisms. Zebrafish are becoming an important model for human disease, since they are easily handled, maintained and manipulated and many fundamental processes between zebrafish and humans are conserved. In addition, the small zebrafish embryo is highly amenable to drug screening assays.

The functional similarity between the initial responses of zebrafish embryo and humans to infection suggests that the zebrafish embryo may be a valuable model for understanding early immune responses and identifying potential therapeutics for infection or immune mediated disease. However, the initial response of zebrafish to infection and how it compares to the human response is not well understood.

When humans first encounter germs, like viruses or bacteria, the first stage of a two-part inflammatory response is triggered, which is termed the innate immune response. During this early phase, proteins are made around the site of infection to initiate the body's defense system and to recruit circulating immune cells, which begins the inflammatory process. A family of proteins that are critical to instigating the immune response are the interferons (IFN), particularly IFN-γ.

Scientists now report that IFN-γ is also produced in zebrafish embryos when they are exposed to bacteria that cause disease in fish. These studies use developing zebrafish embryos whose response to infection is isolated to the innate immune response. Since the zebrafish embryo only demonstrates innate immunity, it allows for specific study of the effects of IFN-γ on these early events. This study demonstrates that both zebrafish and human IFN-γ proteins function in much the same way, despite having very distinct protein structures. In both zebrafish and humans, IFN-γ triggers the production of an array of proteins that rally the defense mechanisms of the infected cell and activate the immune system. They also found that compromising the ability of the zebrafish embryos to produce IFN-γ impairs the fish's ability to survive infection. Thus, the zebrafish embryo may provide a very simple model to understand the innate immune response.

Interestingly, large quantities of bacteria, which would cause septic shock -- a potentially fatal condition -- in humans, do not elicit the same response in zebrafish. This suggests that some key differences between the immune systems of zebrafish and humans may also provide insight into harmful events associated with inflammation.

The characterization of IFN-γ function in zebrafish is presented in an article appearing in the November/December 2009 issue of the new research journal, Disease Models & Mechanisms (DMM), published by The Company of Biologists, a non-profit based in Cambridge, UK.


Story Source:

The above story is based on materials provided by The Company of Biologists. Note: Materials may be edited for content and length.


Journal Reference:

  1. D. Sieger, C. Stein, D. Neifer, A. M. van der Sar, M. Leptin. The role of gamma interferon in innate immunity in the zebrafish embryo. Disease Models & Mechanisms, 2009; 2 (11-12): 571 DOI: 10.1242/dmm.003509

Cite This Page:

The Company of Biologists. "Fish Fend Off Invading Germs With An Initial Response Similar To One Found In Humans." ScienceDaily. ScienceDaily, 26 September 2009. <www.sciencedaily.com/releases/2009/09/090924093341.htm>.
The Company of Biologists. (2009, September 26). Fish Fend Off Invading Germs With An Initial Response Similar To One Found In Humans. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/09/090924093341.htm
The Company of Biologists. "Fish Fend Off Invading Germs With An Initial Response Similar To One Found In Humans." ScienceDaily. www.sciencedaily.com/releases/2009/09/090924093341.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins